effect sulfonylurea adipocyt skelet muscl insulin action patient non-insulin-depend diabet mellitu effect glibenclamid treatment insulin action isol fat cell obes patient non-insulin-depend diabet niddm insulin receptor bind effect insulin glucos transport lipogenesi month glibenclamid therapi end treatment period mean daytim plasma glucos concentr versu mmol/l wherea daytim plasma insulin level versu mu/l adipocyt insulin receptor bind basal glucos transport metabol drug treatment contrast insulin-stimul glucos transport lipogenesi find compar studi obes subject niddm biopsi later vastu muscl measur insulin receptor function glycogen synthas activ month gliclazid treatment studi insulin receptor wheatgerm agglutinin unchang insulin bind receptor kinas activ gliclazid impact maxim glycogen synthas activ physiolog hyperinsulinem condit therapi increas sensit glycogen synthas alloster activ conclus sulfonylurea treatment niddm insulin-stimul peripher glucos util part potenti insulin action adipos tissu glucos transport lipogenesi skelet muscl glycogen synthas 